Senior insider sale
Chief Development Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$234.9K
26.07K shares
What this filing means
MYLES DAVID C. plans to sell 26.07K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $234.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2024ACC: 0001959173-24-008598
Officer· Chief Development Officer
Since Nov 2020
26.07K
Shares to sell
$234.9K
Approx. market value
13.61K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
12/10/2024
13.61KTotal acquired13.61K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2024 | Restricted Stock Vesting Compensation | 13.61K | — |
| Total | 13.61K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
12.45K
Market value
$116.7K
12/10/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.61K
Market value
$118.2K
12/11/2024
Total
Units
26.07K
Value
$234.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/10/2024 | 12.45K | $116.7K | — | Completed |
| Planned — Approximate Date | ||||
12/11/2024 | 13.61K | $118.2K | NASDAQ | Planned |
| Total | 26.07K | $234.9K | ||